This report examines the evolution of pharmaceuticals and biotechnology, highlighting their implications for ethics and access.
The pharmaceutical and biotechnology industries are experiencing rapid and multidimensional evolution, driven by advances in chemistry, biologics, data analytics, formulation, as well as regulatory and ethical frameworks [...]
No takes yet. Share an insight, caveat, or question.
Fernando Alberício (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: